Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
11 CDC (Subcut Injection PDF)Technique diagram and site guidance for subcutaneous injections
To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients conditions and possible contraindications or dangers in use, review of any applicable manufacturers product information, and comparison with recommendations of other authorities
Administration: The injection typically takes only a few minutes
Dahan, A., et al
Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
US$ 29.33
US$ 28.63
US$ 24.38
US$ 20.53
US$ 25.35
US$ 21.46
US$ 26.13